advisorsecurities master

RNAAtrium Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
21058
Ticker
RNA
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2026-02-27
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
RNA

Detail

Enriched 2026-08-14 20:47

Market cap
$208,175,675.31
Shares outstanding (class)
17,105,643
Shares outstanding (weighted)
17,105,643
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
391
Location
SAN DIEGO, CA
Description

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data